Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

DPH1 gene

Known as: DPH2-LIKE 1, DPH1, S. CEREVISIAE, HOMOLOG OF, DPH2L1 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Moxetumomab pasudotox (HA22) is an immunotoxin with an anti-CD22 Fv fused to a portion of Pseudomonas exotoxin A that kills CD22… Expand
Highly Cited
2012
Highly Cited
2012
Abstract This study extensively presents the Automatic Generation Control (AGC) application of Artificial Bee Colony (ABC… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 5
Highly Cited
2004
Highly Cited
2004
Loss of OVCA1/DPH2L1 correlates with ovarian and breast cancer. To study its in vivo role, we generated Ovca1 mutant alleles in… Expand
Highly Cited
2004
Highly Cited
2004
ABSTRACT Diphthamide, a posttranslational modification of translation elongation factor 2 that is conserved in all eukaryotes and… Expand
  • figure 1
  • table 1
  • table 2
  • table 4
  • figure 3
2002
2002
Retinoids, the natural and synthetic derivatives of vitamin A, have been shown to regulate the growth and differentiation of a… Expand
2000
2000
The OVCA1 gene is a candidate for the breast and ovarian tumor suppressor gene at chromosome 17p13.3. To help determine the… Expand
Highly Cited
1999
Highly Cited
1999
Using the N‐terminus of cyclin A1 in a two‐hybrid screen as a bait, we identified a Xenopus protein, XDRP1, that contains a… Expand
Highly Cited
1999
Highly Cited
1999
Loss of all or part of one copy of chromosome 17p is very common in ovarian and breast tumors. OVCA1 is a candidate tumor… Expand
Highly Cited
1998
Highly Cited
1998
The spindle assembly checkpoint pathway is not essential for normal mitosis but ensures accurate nuclear division by blocking the… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
1996
Highly Cited
1996
A second tumor suppressor locus on 17p that is distinct from TP53 has been identified in brain, breast, lung, and ovarian tumors… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4